Pulse Biosciences (NASDAQ:PLSE – Get Free Report) and PetVivo (OTCMKTS:PETV – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Volatility & Risk Pulse Biosciences has a beta […]
Pulse Biosciences, Inc. (NASDAQ:PLSE – Get Rating) Director Robert W. Duggan purchased 10,022,937 shares of Pulse Biosciences stock in a transaction dated Tuesday, May 9th. The shares were purchased at an average cost of $6.51 per share, for a total transaction of $65,249,319.87. Following the completion of the transaction, the director now owns 30,414,661 shares […]
Pulse Biosciences (NASDAQ:PLSE – Get Rating) and Paragon 28 (NYSE:FNA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk. Volatility and Risk Pulse Biosciences has a beta of […]
StockNews.com upgraded shares of Pulse Biosciences (NASDAQ:PLSE – Get Rating) to a sell rating in a research note published on Tuesday morning. Pulse Biosciences Trading Down 4.2 % Shares of NASDAQ PLSE opened at $3.67 on Tuesday. Pulse Biosciences has a 1-year low of $1.18 and a 1-year high of $4.58. The company has a […]
Pulse Biosciences (NASDAQ:PLSE – Get Rating) was upgraded by research analysts at StockNews.com to a “sell” rating in a research note issued on Tuesday. Pulse Biosciences Stock Down 6.8 % PLSE stock traded down $0.29 during midday trading on Tuesday, hitting $3.95. 142,844 shares of the company’s stock were exchanged, compared to its average volume […]